Toxoplasmosis in patients with hematologic malignancies

Leuk Lymphoma. 2015 Feb;56(2):536-8. doi: 10.3109/10428194.2014.926348. Epub 2014 Jul 17.

Authors

Ashish Chintakuntlawar¹, Michael Kidd, Aref Al-Kali, Walter Wilson, Carrie A Thompson

Affiliation

¹ Division of Hematology/Department of Internal Medicine.

PMID: 24882256
DOI: 10.3109/10428194.2014.926348

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bendamustine Hydrochloride / administration & dosage
Bendamustine Hydrochloride / adverse effects
Diagnosis, Differential
Female
Hematologic Neoplasms / diagnosis
Hematologic Neoplasms / drug therapy*
Humans
Rituximab / administration & dosage
Rituximab / adverse effects
Toxoplasma / isolation & purification*
Toxoplasma / physiology
Toxoplasmosis, Cerebral / chemically induced
Toxoplasmosis, Cerebral / diagnosis*
Toxoplasmosis, Cerebral / parasitology

Substances

Rituximab
Bendamustine Hydrochloride